Geneos Wealth Management’s First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF HYLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$514K Buy
12,640
+25
+0.2% +$1.02K 0.01% 726
2026
Q1
$512K Sell
12,615
-282
-2% -$11.7K 0.01% 693
2025
Q4
$540K Sell
12,897
-1,449
-10% -$60.6K 0.01% 639
2025
Q3
$603K Sell
14,346
-127,022
-90% -$5.32M 0.02% 601
2025
Q2
$5.91M Buy
141,368
+87,299
+161% +$3.59M 0.14% 173
2025
Q1
$2.22M Buy
54,069
+3,663
+7% +$152K 0.07% 289
2024
Q4
$2.08M Buy
50,406
+2,956
+6% +$123K 0.07% 283
2024
Q3
$1.99M Buy
47,450
+34,347
+262% +$1.42M 0.08% 281
2024
Q2
$532K Sell
13,103
-881
-6% -$35.8K 0.02% 482
2024
Q1
$577K Buy
13,984
+111
+0.8% +$4.57K 0.03% 464
2023
Q4
$577K Sell
13,873
-685
-5% -$27.3K 0.03% 446
2023
Q3
$571K Buy
14,558
+66
+0.5% +$2.62K 0.03% 440
2023
Q2
$574K Sell
14,492
-1,275
-8% -$50.5K 0.03% 433
2023
Q1
$627K Hold
15,767
0.04% 398
2022
Q4
$614K Buy
15,767
+650
+4% +$25.6K 0.04% 376
2022
Q3
$579K Buy
15,117
+486
+3% +$19.8K 0.04% 366
2022
Q2
$576K Sell
14,631
-2,060
-12% -$87.3K 0.03% 461
2022
Q1
$763K Sell
16,691
-1,194
-7% -$55.3K 0.03% 433
2021
Q4
$855K Sell
17,885
-1,507
-8% -$72K 0.03% 443
2021
Q3
$936K Buy
19,392
+460
+2% +$22.2K 0.04% 401
2021
Q2
$921K Buy
18,932
+651
+4% +$31.7K 0.04% 382
2021
Q1
$888K Buy
18,281
+330
+2% +$16.1K 0.02% 454
2020
Q4
$853K Buy
17,951
+1,144
+7% +$55K 0.03% 397
2020
Q3
$786K Buy
16,807
+960
+6% +$45.4K 0.04% 338
2020
Q2
$726K Buy
15,847
+840
+6% +$38.1K 0.04% 338
2020
Q1
$630K Sell
15,007
-535
-3% -$25K 0.04% 333
2019
Q4
$758K Buy
15,542
+2,485
+19% +$120K 0.04% 351
2019
Q3
$629K Buy
13,057
+327
+3% +$15.8K 0.04% 364
2019
Q2
$612K Buy
12,730
+5,525
+77% +$266K 0.04% 363
2019
Q1
$344K Buy
7,205
+4,335
+151% +$205K 0.02% 498
2018
Q4
$128K Buy
2,870
+400
+16% +$18.7K 0.01% 752
2018
Q3
$118K Buy
2,470
+1,890
+326% +$90.1K 0.01% 827
2018
Q2
$27K Buy
580
+300
+107% +$14.3K ﹤0.01% 1330
2018
Q1
$13K Hold
280
﹤0.01% 1548
2017
Q4
$13K Hold
280
﹤0.01% 1540
2017
Q3
$13K Buy
280
+70
+33% +$3.45K ﹤0.01% 1479
2017
Q2
$10K Hold
210
﹤0.01% 1531
2017
Q1
$10K Hold
210
﹤0.01% 1479
2016
Q4
$10K Buy
+210
New +$10.1K ﹤0.01% 1426

Other funds holding HYLS

Geneos Wealth Management's HYLS Position: Q2 2026 in Review

Geneos Wealth Management increased its First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF (HYLS) stake by 0.2% in Q2 2026, buying an estimated $1.02K and bringing the position to 12,640 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #726.

Geneos Wealth Management first reported a position in HYLS in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.91M in Q2 2025. 215 funds tracked by Wall St. Rank hold HYLS as of Q2 2026.

  • Geneos Wealth Management held 12,640 shares of First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF worth $514K as of Q2 2026.
  • Geneos Wealth Management bought 25 First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF shares in Q2 2026, an estimated $1.02K.
  • First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #726 holding.
  • Geneos Wealth Management first reported a position in First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2016 and has held it in 39 quarters since.
  • Geneos Wealth Management's First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF position peaked at $5.91M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.